All articles by Soumya Sharma

UCLA Health to begin trial of personalised brain cancer vaccine

UCLA Health Jonsson Comprehensive Cancer Center is set to initiate a clinical trial of a personalised cancer vaccine aimed at…
Armata completes Phase II Tailwind study enrollment in US

Armata Pharmaceuticals has completed patient enrollment for its Phase II Tailwind study for inhaled bacteriophage therapy AP-PA02, targeting chronic pulmonary…
Olatec initiates dapansutrile Phase II diabetes trial

Olatec Therapeutics has started a Phase II clinical trial for its NLRP3 inhibitor, dapansutrile, targeting patients with type 2 diabetes (T2D)…
FDA approves Biophytis’ Phase II OBA obesity study

Biophytis has obtained investigational new drug (IND) approval from the US Food and Drug Administration (FDA) to initiate its Phase…
YolTech doses first subject in Phase I trial for YOLT-201 therapy

China-based YolTech Therapeutics has dosed the first patient as part of its Phase I clinical trial for gene editing therapy…

Vertex advances APOL1 kidney disease therapy to Phase III portion of trial

Vertex Pharmaceuticals has confirmed the progression of inaxaplin (VX-147) into the Phase III portion of the international Phase II/III pivotal…
Eli Lilly begins Phase III trials of oral weight loss drug in India

Eli Lilly has reportedly commenced Phase III clinical trials of oral medication, orforglipron, for weight loss in India. The oral…
Life sciences software company Benchling trims workforce by 9%

Benchling, a US-based life sciences software company, has confirmed that it has laid off around 9% of its workforce. The…